Unlike single or dual-action treatments, Retatrutide targets the GLP-1, GIP, and glucagon receptors all at once
These findings underscore that the CeA is a key integrative hub in which GLP1 signalling, both pharmacologically induced and naturally occurring, converges to curb hedonic feeding 44
The bigger, long-term question is: if patients become significantly healthier through these medications, will they still need treatments for heart disease, high cholesterol, and related conditions
But as research evolves, so may the rules
P.MllerS.HviidA
The medication removes the barrier of constant hunger, allowing you to focus mental energy on lifestyle changes